22 days ago
IRWD
AnalystsJason N. ButlerJason N. Butler's Stock Forecasts
AnalystsJason N. Butler
Analyst Ranking
Bottom 12%
#4610 out of 5221 analysts
Average Return
-6.98%
Win Rate
38%6 out of 16
Risk vs Reward
Poor
Good
Jason N. Butler's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Abivax SaABVX | +50.03% | $82.00 | $123.03 | 2025-09-25 - 2026-03-19 | Buy |
Cytokinetics IncCYTK | +26.86% | $49.62 | $62.95 | 2025-09-02 - 2026-03-19 | Buy |
Terawulf IncWULF | +8.55% | $14.50 | $15.74 | 2025-10-29 - 2026-03-19 | Buy |
Rapport Therapeutics IncRAPP | +7.01% | $25.66 | $27.46 | 2025-11-07 - 2026-03-19 | Buy |
Esperion Therapeutics IncESPR | +6.56% | $2.44 | $2.60 | 2026-03-13 - 2026-03-19 | Buy |
Jason N. Butler Analyst Color
Get additional color on Jason N. Butler's coverage of popular stocks
Jason N. Butler's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Esperion Therapeutics IncESPR | 1 | Buy | $5.00 | +92.31% | Maintains | 7 days ago |
Gh Research PLCGHRS | 1 | Buy | $42.00 | +183.59% | Maintains | 14 days ago |
Argenx SeARGX | 1 | Buy | $944.00 | +37.91% | Maintains | 21 days ago |
Ironwood Pharmaceuticals IncIRWD | 1 | Buy | $10.00 | +209.60% | Maintains | 22 days ago |
Acadia Pharmaceuticals IncACAD | 3 | Buy | $35.00 | +68.92% | Maintains | 22 days ago |
Achieve Life Sciences IncACHV | 1 | Buy | $19.00 | +364.55% | Initiates Coverage On | 4 months ago |
Rapport Therapeutics IncRAPP | 1 | Buy | $80.00 | +191.33% | Maintains | 4 months ago |
Terawulf IncWULF | 1 | Buy | $22.00 | +39.77% | Maintains | 5 months ago |
Rezolute IncRZLT | 1 | Buy | $17.00 | +588.26% | Maintains | 5 months ago |
Abivax SaABVX | 1 | Buy | $114.00 | -7.34% | Maintains | 6 months ago |
Cormedix IncCRMD | 1 | Buy | $22.00 | +249.21% | Reiterates | 6 months ago |
Cytokinetics IncCYTK | 1 | Buy | $78.00 | +23.91% | Reiterates | 7 months ago |
Precigen IncPGEN | 1 | Buy | $8.00 | +140.96% | Maintains | 7 months ago |
Zevra Therapeutics IncZVRA | 1 | Buy | $18.00 | +91.49% | Maintains | 7 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.